Horn et al. found that high level of c-MYC expression (and/or c-MYC rearrangement status) in concert with BCL2 high and BCL6 low status emerged as critical prognostic variables with comparable relative risks for both event-free survival and overall survival in DLBCL (15). This evidence concerns the gene BCL6 and diffuse large B-cell lymphoma.